Jacob E. Berchuck

2.1k total citations
39 papers, 544 citations indexed

About

Jacob E. Berchuck is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jacob E. Berchuck has authored 39 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Jacob E. Berchuck's work include Prostate Cancer Treatment and Research (17 papers), Cancer Genomics and Diagnostics (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Jacob E. Berchuck is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Cancer Genomics and Diagnostics (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Jacob E. Berchuck collaborates with scholars based in United States, Canada and Italy. Jacob E. Berchuck's co-authors include Himisha Beltran, Ana M. Aparicio, Mary‐Ellen Taplin, Matthew L. Freedman, Richard M. Stone, Daniel J. DeAngelo, Todd R. Golub, Ilene Galinsky, Kimberly Stegmaier and Rana R. McKay and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Jacob E. Berchuck

32 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob E. Berchuck United States 12 248 225 142 124 69 39 544
Samuel Pan United States 12 298 1.2× 273 1.2× 139 1.0× 101 0.8× 71 1.0× 41 552
Teresa M. Hopper United States 4 243 1.0× 231 1.0× 101 0.7× 204 1.6× 35 0.5× 6 486
Spyridon P. Basourakos United States 14 171 0.7× 317 1.4× 120 0.8× 164 1.3× 17 0.2× 67 652
Hamid Mirshahidi United States 12 164 0.7× 212 0.9× 134 0.9× 291 2.3× 24 0.3× 43 609
Kwai Han Yoo South Korea 15 183 0.7× 210 0.9× 83 0.6× 270 2.2× 85 1.2× 50 588
Sarah Burkhead Whittle United States 13 228 0.9× 87 0.4× 124 0.9× 110 0.9× 20 0.3× 33 546
Amit Mehta United States 12 197 0.8× 300 1.3× 115 0.8× 183 1.5× 15 0.2× 18 667
Peggy S. Esper United States 11 101 0.4× 319 1.4× 99 0.7× 167 1.3× 29 0.4× 16 521
C.S. Foster United Kingdom 12 151 0.6× 259 1.2× 110 0.8× 56 0.5× 51 0.7× 31 497

Countries citing papers authored by Jacob E. Berchuck

Since Specialization
Citations

This map shows the geographic impact of Jacob E. Berchuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Berchuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Berchuck more than expected).

Fields of papers citing papers by Jacob E. Berchuck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob E. Berchuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Berchuck. The network helps show where Jacob E. Berchuck may publish in the future.

Co-authorship network of co-authors of Jacob E. Berchuck

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob E. Berchuck. A scholar is included among the top collaborators of Jacob E. Berchuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob E. Berchuck. Jacob E. Berchuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Travis, John Canniff, Renée Maria Saliby, et al.. (2025). Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 253–253.
2.
3.
Liu, Yuan, Dylan J. Martini, Wayne Harris, et al.. (2025). Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.. Journal of Clinical Oncology. 43(5_suppl). 512–512. 1 indexed citations
4.
Stopsack, Konrad H., Joseph Vijai, Jacob E. Berchuck, et al.. (2024). Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer. Clinical Cancer Research. 31(1). 122–129. 5 indexed citations
5.
Ravi, Praful, Dory Freeman, Jonathan Thomas, et al.. (2024). Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer. Journal for ImmunoTherapy of Cancer. 12(2). e008215–e008215. 2 indexed citations
6.
Berchuck, Jacob E., et al.. (2024). Unearthing a Prostate Cancer cfDNA Signature that “Stems” from AR Alterations. Clinical Cancer Research. 31(1). 7–9.
7.
8.
Berg, Stephanie, Charlene Mantia, Matthew Mossanen, et al.. (2024). Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in patients with muscle-invasive bladder cancer (MIBC) undergoing trimodality therapy (TMT).. Journal of Clinical Oncology. 42(16_suppl). e16606–e16606. 1 indexed citations
9.
Mantia, Charlene, Anurag Saraf, Mark A. Preston, et al.. (2024). Correlation of Circulating Tumor DNA (ctDNA) Dynamics with Clinical Response in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Trimodality Therapy (TMT). International Journal of Radiation Oncology*Biology*Physics. 120(2). e564–e565. 1 indexed citations
10.
11.
Lü, Xiaodong, Ka-wing Fong, Galina Gritsina, et al.. (2022). HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature Genetics. 54(5). 670–683. 58 indexed citations
12.
Berchuck, Jacob E., Zhenwei Zhang, Rebecca Silver, et al.. (2021). Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer. European Urology. 80(3). 295–303. 16 indexed citations
13.
Berchuck, Jacob E., et al.. (2021). Clinical considerations for the management of androgen indifferent prostate cancer. Prostate Cancer and Prostatic Diseases. 24(3). 623–637. 42 indexed citations
14.
Bakouny, Ziad, Emre Yekedüz, David A. Braun, et al.. (2021). Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 166. 103463–103463. 4 indexed citations
15.
Adra, Nabil, Alexandra Sokolova, Adam Kessel, et al.. (2021). Differential activity of PARP inhibitors in BRCA1- versus BRCA2-altered metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 39(6_suppl). 100–100. 7 indexed citations
16.
Nassar, Amin H., Lana Hamieh, Jacob E. Berchuck, et al.. (2020). Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma. Genetics in Medicine. 22(8). 1366–1373. 51 indexed citations
17.
Nassar, Amin H., Sarah Abou Alaiwi, Saud H. AlDubayan, et al.. (2019). Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. Genetics in Medicine. 22(4). 709–718. 38 indexed citations
18.
Berchuck, Jacob E. & Shalini Patel. (2015). An Often-Overlooked Etiology of Pleuritic Chest Pain. Journal of General Internal Medicine. 31(1). 138–138. 2 indexed citations
19.
Berchuck, Jacob E., et al.. (2013). All-trans-Retinal Sensitizes Human RPE Cells to Alternative Complement Pathway–Induced Cell Death. Investigative Ophthalmology & Visual Science. 54(4). 2669–2669. 15 indexed citations
20.
Hahn, Cynthia K., Jacob E. Berchuck, Kenneth N. Ross, et al.. (2009). Proteomic and Genetic Approaches Identify Syk as an AML Target. Cancer Cell. 16(4). 281–294. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Pan Breakdown of academic impact, for papers by Teresa M. Hopper Breakdown of academic impact, for papers by Spyridon P. Basourakos Breakdown of academic impact, for papers by Hamid Mirshahidi Breakdown of academic impact, for papers by Kwai Han Yoo Breakdown of academic impact, for papers by Sarah Burkhead Whittle Breakdown of academic impact, for papers by Amit Mehta Breakdown of academic impact, for papers by Peggy S. Esper Breakdown of academic impact, for papers by C.S. Foster
Rankless by CCL
2026